This inventor holds 6 USPTO granted patents and 20 published patent applications and 7 EPO patents. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mazkeret Batia, IL (2019 - 2021)
- Jerusalem, IL (2022)
- Rehovot, IL (2023 - 2024)
Company Filing History:
Years Active: 2019-2024
Title: Eran Elinav: Innovator in Microbiome Research
Introduction
Eran Elinav is a prominent inventor based in Mazkeret Batia, Israel. He has made significant contributions to the field of microbiome research, particularly in relation to obesity and dietary responses. With a total of 6 patents, Elinav's work is at the forefront of innovative health solutions.
Latest Patents
One of Elinav's latest patents focuses on microbiome-based diagnosis, prediction, and treatment of relapsing obesity. This method analyzes the likelihood of weight regain in individuals who have achieved target weight through weight loss programs. It involves determining the presence of specific microbes in the gut microbiome, which can indicate the potential for weight regain. Another notable patent is a method for predicting a subject's response to food. This method utilizes databases to estimate how a subject will respond to various foods based on previous responses from similar subjects.
Career Highlights
Eran Elinav has worked with notable organizations such as Yeda Research and Development Company and Keio University. His research has significantly advanced the understanding of the microbiome's role in health and disease.
Collaborations
Elinav has collaborated with esteemed colleagues, including Eran Segal and Zelig Eshhar, to further enhance the impact of his research.
Conclusion
Eran Elinav's innovative work in microbiome research is paving the way for new approaches to obesity treatment and dietary management. His contributions are vital in understanding the complex interactions between gut microbiota and health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile